|
gptkbp:instance_of
|
gptkb:drug
|
|
gptkbp:activities
|
relaxes bronchial muscles
|
|
gptkbp:appointed_by
|
inhalation aerosol
|
|
gptkbp:approves
|
gptkb:1993
gptkb:FDA
|
|
gptkbp:brand
|
gptkb:Combivent_Respimat
|
|
gptkbp:class
|
gptkb:superhero
|
|
gptkbp:clinical_trial
|
Phase III
maintenance therapy
rescue therapy
reduced exacerbations
showed improved lung function
well tolerated in patients
|
|
gptkbp:contains
|
gptkb:ipratropium_bromide
albuterol
|
|
gptkbp:contraindication
|
severe asthma
hypersensitivity to components
acute bronchospasm
|
|
gptkbp:dosage_form
|
aerosol
|
|
gptkbp:duration
|
as needed
|
|
gptkbp:education
|
important for proper use
|
|
gptkbp:formulation
|
metered-dose inhaler
|
|
gptkbp:healthcare
|
combination therapy
|
|
https://www.w3.org/2000/01/rdf-schema#label
|
Combivent
|
|
gptkbp:ingredients
|
gptkb:albuterol_sulfate
gptkb:ipratropium_bromide
|
|
gptkbp:interacts_with
|
beta-blockers
anticholinergic drugs
|
|
gptkbp:invention
|
gptkb:2023
|
|
gptkbp:is_available_on
|
generic version
|
|
gptkbp:is_monitored_by
|
lung function
symptom control
|
|
gptkbp:is_used_for
|
gptkb:asthma
chronic obstructive pulmonary disease
|
|
gptkbp:manager
|
inhalation
|
|
gptkbp:manufacturer
|
gptkb:Boehringer_Ingelheim
|
|
gptkbp:marketed_as
|
gptkb:legislation
gptkb:United_States
gptkb:Native_American_tribe
|
|
gptkbp:packaging
|
pressurized canister
|
|
gptkbp:population
|
adults
children over 12 years
|
|
gptkbp:price
|
varies by pharmacy
|
|
gptkbp:provides_information_on
|
recommended for COPD
recommended for asthma
|
|
gptkbp:requires
|
available online
prescription only
|
|
gptkbp:safety_features
|
available in package insert
|
|
gptkbp:shelf_life
|
3 years
|
|
gptkbp:side_effect
|
dizziness
headache
nausea
cough
dry mouth
tremors
palpitations
throat irritation
|
|
gptkbp:storage
|
room temperature
|
|
gptkbp:type_of_care
|
important for effectiveness
|
|
gptkbp:bfsParent
|
gptkb:Combivent_Respimat
|
|
gptkbp:bfsLayer
|
6
|